HomeSearchJournal of Leukemia and Lymphoma

Journal of Leukemia and Lymphoma

Chinese Medical Journals Publishing House Co.Ltd · China

ISSN1009-9921
SJR Q4Scopus / SJR
Journal Impact Factor
Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.
📊 Standing in its field
Where this journal ranks among others in the same subject area.
Q4
SJR · Scopus
Bottom 25%
Clarivate’s JCR quartile is a separate ranking and may differ
SJR Scorei
0.106
H-Indexi
3
SNIPi
0.019
Total Worksi
1,137
Total Citationsi
90
2yr Mean Citednessi
0.00
Open Impact Factor alternative

Aims & Scope

Subject areas: Cancer Research; Hematology; Oncology.

General Information

Country / RegionChina
Primary Language
1st Year Published
Annual Volume~ 83 articles / year
StatusActive
Total Publications1,137
Publisher OrgChinese Medical Journals Publishing House

Submission Info

Publishing ModelSubscription
Peer Review
OA License
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

4/11 · 36%
Do you know the journal / publisher?
Chinese Medical Journals Publishing House Co.Ltd
Does the journal have a website?
No URL
Is the ISSN verified?
1009-9921
Indexed in a trusted database?
Scopus
Peer review process documented?
N/A
Follows ethical publishing standards (COPE)?
N/A
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
N/A
Plagiarism detection in place?
N/A
Listed in DOAJ (verified OA)?
N/A
Primary language documented?
N/A

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
262
10
2009
241
10
2010
251
7
2011
238
10
2012
219
5
2013
218
15
2014
2
0
2016
28
3
2017

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cancer ResearchQ4
HematologyQ4
OncologyQ4

Subject Classification

Scopus Categories

HematologyCancer ResearchOncology

Research Topics (OpenAlex)

Lymphoma Diagnosis and TreatmentAcute Myeloid Leukemia ResearchChronic Lymphocytic Leukemia ResearchChronic Myeloid Leukemia TreatmentsMultiple Myeloma Research and TreatmentsAcute Lymphoblastic Leukemia researchImmune Cell Function and InteractionMyeloproliferative Neoplasms: Diagnosis and TreatmentRetinoids in leukemia and cellular processesCAR-T cell therapy research

Frequently asked questions about Journal of Leukemia and Lymphoma

Is Journal of Leukemia and Lymphoma a predatory journal?

PubScope has no integrity flags on record for Journal of Leukemia and Lymphoma: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Journal of Leukemia and Lymphoma?

Journal of Leukemia and Lymphoma is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.106.

Is Journal of Leukemia and Lymphoma indexed in Scopus and Web of Science?

Journal of Leukemia and Lymphoma is indexed in Scopus.

What is the aims and scope of Journal of Leukemia and Lymphoma?

Subject areas: Cancer Research; Hematology; Oncology.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref